We're the make our own pancreas type
JDRF is proud to support the first successful real-world test of a revolutionary closed-loop artificial pancreas system, allowing those with T1D to live as normal a life as possible until there's a cure.
We're the see into the future type
JDRF-funded research led to the discovery of Lucentis the first new therapy with the ability to reverse diabetes-related vision loss in 30 years creating a brighter future for millions.
We're the bodyguard for beta cells type
JDRF is funding clinical trials for encapsulated cell therapies, which will restore insulin independence in those with T1D for an incredible 18 months to two years. These therapies implant newly created insulin-producing beta cells into a protective capsule, so they can do their job, and those with T1D can enjoy a little freedom.
We're the making insulin smarter type
JDRF is funding the early development of smart insulin. A single daily dose of insulin circulates in the bloodstream turning on when it's needed and off when it's not giving those with T1D perfect blood-glucose control throughout the day.
We're the help the body do it on its own type
A potential biological cure, JDRF is funding research on restoration, which taps into the body's amazing power to heal itself, restoring beta cells' ability to produce insulin while blocking the autoimmune attack that triggers T1D.
We're the stop it before it starts type
JDRF is currently supporting work on a vaccine to slow or stop the progression of T1D before insulin dependence occurs. For those at risk of T1D, prevention is powerful medicine.